Dilantin and Levofloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Levofloxacin (levofloxacin; sodium chloride). Common drug interactions include escherichia infection among females and dermatitis exfoliative among males.

The phase IV clinical study analyzes what interactions people have when they take Dilantin and Levofloxacin. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,858 Dilantin users. Check the latest studies of Dilantin.

What is Levofloxacin?

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is often used in sinusitis. eHealthMe is studying from 16,335 Levofloxacin users. Check the latest studies of Levofloxacin.



On Aug, 13, 2026

58 people who take Dilantin and Levofloxacin together, and have interactions are studied.

Dilantin and Levofloxacin drug interactions.

What are the common drug interactions of Dilantin and Levofloxacin, by gender? *:

female:

  1. Escherichia infection (bacterial infection by escherichia coli)
  2. Fall
  3. Renal cyst (kidney cyst)
  4. Anaemia (lack of blood)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  9. Back pain
  10. Blood creatinine increased

male:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Alanine aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood chloride decreased
  5. Blood lactate dehydrogenase increased
  6. Blood potassium decreased
  7. Blood sodium decreased
  8. Blood triglycerides increased
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the common drug interactions of Dilantin and Levofloxacin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Pyrexia (fever)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood alkaline phosphatase increased
  6. Hepatic trauma (liver injury)
  7. Hepatitis (inflammation of the liver)
  8. Hepatotoxicity (chemical-driven liver damage)
  9. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  10. Neutropenia (an abnormally low number of neutrophils)

30-39:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Dry skin
  4. Flushing (the warm, red condition of human skin)
  5. Pneumonia pneumococcal (pneumococcal pneumonia is a common but serious infection and inflammation of the lungs)
  6. Pneumonia streptococcal (pneumonia, caused by streptococcus pneumoniae)
  7. Rigors (an episode of shaking or exaggerated shivering)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  10. Toxic shock syndrome (a rare but serious medical condition caused by a bacterial infection)

40-49:

  1. Diaphragmatic paralysis (acquired dysfunction of the phrenic nerve)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Hepatitis (inflammation of the liver)
  4. Lethargy (tiredness)
  5. Body temperature increased
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Fatigue (feeling of tiredness)
  10. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

50-59:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  7. Aphthous stomatitis (mouth ulcer)
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Asthma
  10. Atelectasis (partial or complete collapse of the lung)

60+:

  1. Anaemia (lack of blood)
  2. Blood lactate dehydrogenase increased
  3. Arteriosclerosis (thickening and hardening of arteries)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  6. Back pain
  7. Blood creatinine increased
  8. Bone disorder
  9. Bone fissure
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 9 people, 15.52%
  2. High Blood Cholesterol: 4 people, 6.90%
  3. Pneumonia: 3 people, 5.17%
  4. Pharyngitis (inflammation of the pharynx, causing a sore throat): 3 people, 5.17%
  5. Constipation: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Levofloxacin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilantin and Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and levofloxacin; sodium chloride (the active ingredients of Dilantin and Levofloxacin, respectively), and Dilantin and Levofloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: